TELL is transforming the early detection of neurodegenerative disorders, leading to progressive damage to brain cells and nervous system connections which are essential for mobility, cognition, and social interaction. Early detection is crucial for enabling lifestyle changes and interventions that can delay the onset of severe symptoms as these diseases progress. TELL utilizes advanced speech-based technology to quickly and objectively assess brain health detecting the presence and severity of disorders like Alzheimer’s, Parkinson’s, and more.
- CEOFernando Johann
- CSOAdolfo García